دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process
Brant J Oliver, PhD, MS, MPH, Alice M Kennedy, MPH, Welmoed K van Deen, PhD, MD, S Alandra Weaver, MPH, Caren Heller, MD, MBA, Megan M Holthoff, MSHS, Jeffrey Bank, MD, Gil Y Melmed, MD, MS, Corey A Siegel, MD, MS, Eugene C Nelson, DSc, MPH
doi : 10.1093/ibd/izab091
Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease
Giorgos Bamias, MD, PhD, Theresa T Pizarro, PhD, Fabio Cominelli, MD, PhD
doi : 10.1093/ibd/izab251
Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis
Catarina Geraldes de Frias Gomes, MD, Alexandra Sofia Ribeiro de Almeida, MS, Catarina Callé Lucas Mendes, MD, Pierre Ellul, MD, PhD, Johan Burisch, MD, PhD, Tiffany Buhagiar, MD, Abigail Attard, MD, MRCP, Bobby Lo, MD, Ryan C Ungaro, MD, MS, Bárbara Tonilhas da Silva Morão, MD, Catarina Ferreira Gouveia, MD, Joana Milheiro Delgado de Carvalho e Branco, MD, Jaime Manuel Martins Pereira Rodrigues, MD, Cristina Teixeira, MD, Maria Francisca Faria Dias de Castro, MD, Gonçalo Filipe Domingos Nunes, MD, MSc, Mariana Brito, MD, MarÃlia Cristina de Sousa Antunes, PhD, Paula Maria Ferreira Brinca Borralho Nunes, MD, PhD, Joana Maria Tinoco da Silva Torres, MD, PhD
doi : 10.1093/ibd/izab069
Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients
Kaustav P Shah, BS, Austin J Triana, BS, Roman E Gusdorf, BS, Allison B McCoy, PhD, MS, Baldeep Pabla, MD, Elizabeth Scoville, MD, Robin Dalal, MD, Dawn B Beaulieu, MD, David A Schwartz, MD, Michelle L Griffith, MD, Sara N Horst, MD, MPH
doi : 10.1093/ibd/izab068
Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016
Siddharth Singh, MD, Alexander S Qian, Nghia H Nguyen, MD, Stephanie K M Ho, MD, Jiyu Luo, MS, Vipul Jairath, MD, William J Sandborn, MD, Christopher Ma, MD
doi : 10.1093/ibd/izab074
Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
Stefanie Howaldt, MD, Eugeni Domènech, MD, PhD, Nicholas Martinez, MD, Carsten Schmidt, MD, Bernd Bokemeyer, MD on behalf of the AEGIS Trialists
doi : 10.1093/ibd/izab073
Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease
Motasem Alkhayyat, MD, Mohammad Abureesh, MD, Ashraf Almomani, MD, Mohannad Abou Saleh, MD, Mohammad Zmaili, MD, Sara El Ouali, MD, Emad Mansoor, MD, Alberto Rubio-Tapia, MD, Miguel Regueiro, MD
doi : 10.1093/ibd/izab084
Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease
Ganit Goren, MSW, Doron Schwartz, MD, Michael Friger, PhD, Hagar Banai, MD, Ruslan Sergienko, MA, Shirley Regev, PhD, Heba Abu-Kaf, MD, Dan Greenberg, PhD, Anna Nemirovsky, MA, Karny Ilan, Livnat Lerner, Alon Monsonego, PhD, Iris Dotan, MD, Henit Yanai, MD, Rami Eliakim, MD, Shomron Ben Horin, MD, Vered Slonim-Nevo, PhD, Shmuel Odes, MD, Orly Sarid, PhD on behalf of the Israeli IBD Research Nucleus
doi : 10.1093/ibd/izab083
The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn’s Disease
Audrey Bennett, MD, Alexander Mamunes, MD, Mindy Kim, PharmD, Caroline Duley, NP, Ailish Garrett, NP, Kim Annis, MS, PA-C, Julianne Wagnon, NP, JD, Robin Dalal, MD, Elizabeth Scoville, MD, Dawn Beaulieu, MD,David Schwartz, MD, Sara Horst, MD, MPH
doi : 10.1093/ibd/izab104
Early-Life Exposure to Antibiotics and Risk for Crohn’s Disease: A Nationwide Danish Birth Cohort Study
Anders Mark-Christensen, MD, PhD, Aksel Lange, MD, PhD, Rune Erichsen, MD, PhD, Trine Frøslev, MSc, Buket Öztürk Esen, MSc, Henrik Toft Sørensen, MD, PhD, DMSc, Michael D Kappelman, MD, MPH
doi : 10.1093/ibd/izab085
The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis
Jens Walldorf, MD, Marc Porzner, MD, Martin Neumann, MD, Golsa Joodi, MD, Jan Hendrik Niess, MD, Georg von Boyen, MD, Karsten Mäder, PhD, Julia Weissbach, PhD, Alexander Kleger, MD, Thomas Seufferlein, MD
doi : 10.1093/ibd/izab191
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis
Mina Hassan-Zahraee, PhD, Zhan Ye, PhD, Li Xi, MBA, MSc, Mary Lynn Baniecki, PhD, Xingpeng Li, PhD, Craig L Hyde, PhD, Jenny Zhang, MD, Nancy Raha, MS, RAC, Fridrik Karlsson, PhD, Jie Quan, PhD, Daniel Ziemek, PhD, Srividya Neelakantan, PhD, Christopher Lepsy, PhD, Jessica R Allegretti, MD, MPH, Jacek Romatowski, MD, PhD, Ellen J Scherl, MD, FACP, FACG, AGAF, FASGE, Maria Klopocka, MD, PhD, Silvio Danese, MD, PhD, Deepa E Chandra, MPharm, Uwe Schoenbeck, PhD, Michael S Vincent, MD, PhD, Randy Longman, MD, PhD, Kenneth E Hung, MD, PhD
doi : 10.1093/ibd/izab193
Germline Alterations in Patients With IBD-associated Colorectal Cancer
Giuseppe Biscaglia, MD, Anna Latiano, BsC, Stefano Castellana, PhD, Rosanna Fontana, BsC, Annamaria Gentile, TLSB, Tiziana Latiano, TLSB, Giuseppe Corritore, TLSB, Anna Panza, PhD, Marianna Nardella, Giuseppina Martino, Fabrizio Bossa, MD, Francesco Perri, MD, Tommaso Mazza, PhD, Angelo Andriulli, MD, Orazio Palmieri, BsC
doi : 10.1093/ibd/izab195
Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis
Ferdinando Nicoletti, MD, Laura Hammer, BA, Stacia Furtado, PhD, Katia Mangano, PhD, Edith Mathiowitz, PhD, Benjamin Green, BS, Dominick L Auci, PhD
doi : 10.1093/ibd/izab204
The Impact of Alcohol in Inflammatory Bowel Diseases
Bradley A White, MD, Guilherme Piovezani Ramos, MD, Sunanda Kane, MD MSPH
doi : 10.1093/ibd/izab089
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association
Andrea Costantino, MD, Daniele Noviello, MD, Francesco Simone Conforti, MD, Marina Aloi, MD, Alessandro Armuzzi, MD, Fabrizio Bossa, MD, Ferdinando Ficari, MD, Salvo Leone, Francesco Manguso, MD, Giammarco Mocci, MD, Ambrogio Orlando, MD, Loris Pironi, MD, Simona Radice, Fernando Rizzello, MD, Alessandra Tongiorgi, MSc, Claudio Costantino, MD, PhD, Maurizio Vecchi, MD, Flavio Caprioli, MD, PhD
doi : 10.1093/ibd/izab172
Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature
David Dulaney, MD, Priya Dave, BA, Samantha Walsh, MLS, MA, Saurabh Mehandru, MD, Jean-Frederic Colombel, MD, Manasi Agrawal, MD, MS
doi : 10.1093/ibd/izab212
Disease Flares in the Postpartum Period: Vigilance Is Key
Ankita Tirath, MD, Sunanda V Kane, MD MSPH
doi : 10.1093/ibd/izab108
Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind?
Sari M Herman, MD, Karver Zaborniak, MD, Charles N Bernstein, MD
doi : 10.1093/ibd/izab183
Addressing COVID-19 Vaccine Hesitancy in Patients with IBD
Dania Hudhud, MD, Freddy Caldera, DO, MS, Raymond K Cross, MD, MS
doi : 10.1093/ibd/izab241
Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
Stefanie Howaldt, MD, Eugeni Domènech, MD, PhD, Nicholas Martinez, MD, Carsten Schmidt, MD, Bernd Bokemeyer, MD on behalf of the AEGIS Trialists
doi : 10.1093/ibd/izab224
Jaundice in a Primary Sclerosing Cholangitis Patient: A New Cause in a New Era
Nik Arsyad Nik Muhamad Affendi, MD, Sarala Ravindran, MD, Tan Soek Siam, MD, Alex Hwong-Ruey Leow, MD, Ida Hilmi, MRCP, PhD
doi : 10.1093/ibd/izab250
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn’s Disease
Carmelo Sofia, MD, Veronica Adiletta, MD, Bruno Iovene, MD, Giacomo Sgalla, MD, PhD, Luca Richeldi, MD, PhD
doi : 10.1093/ibd/izab255
Tracheobronchial Crohn’s Disease: Case Report and Systematic Review of the Literature
Rao G Raghava, MD, DM, Vishal Sharma, MD, DM, Srikant Kashinath Malegaonkar, MD, Sahajal Dhooria, MD, DM, Inderpaul Singh Sehgal, MD, DM, Kuruswamy Thurai Prasad, MD,DM, Amanjit Bal, MD, Ritesh Agarwal, MD, DM, Valliappan Muthu, MD, DM
doi : 10.1093/ibd/izab258
Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab
Cong Dai, PhD, MD, Yu-hong Huang, MD, Min Jiang, MD
doi : 10.1093/ibd/izab260
Response to “Strongyloides stercoralis in Acute Severe Ulcerative Colitis—A Triggering Nuisance or an Opportunistic Bystander?�
Akira Hokama, MD, PhD, Jiro Fujita, MD, PhD
doi : 10.1093/ibd/izab261
Reply to Response to “Strongyloides stercoralis in Acute Severe Ulcerative Colitis—A Triggering Nuisance or an Opportunistic Bystander?� by Hokama et al
Anurag Sachan, MD, Anupam Kumar Singh, MD, DM
doi : 10.1093/ibd/izab262
Spontaneous Perforation in Crohn’s Disease: A Report of Two Cases
Bingqing Yu, MS, Chuangzhen Lin, MD, Yuping Yang, MS, Ya-Feng Yang, MS, Biao Nie, MD, PhD
doi : 10.1093/ibd/izab264
Refractory Immune Checkpoint Inhibitor-induced Colitis Improved by Fecal Microbiota Transplantation: A Case Report
Cong Dai, MD, PHD, Wei-Xin Liu, MD, PhD
doi : 10.1093/ibd/izab265
